In contrast with the adverse activity of Cav-1 in the present model, a previous investigation using a 2,4,6-trinitrobenzenesulfonic acid-induced colitis model suggested that Cav-1 played protective roles against intestinal inflammation with no molecular evidence of its effects33. The gene discussed is CAV1; the disease is colitis.